Bayer BAYN-1.22%decrease; red down pointing triangle said it agreed to buy Perfuse Therapeutics for up to $2.45 billion, snapping up an eye-drug specialist that is developing a potential glaucoma ...
Bayer has struck a deal to buy Perfuse Therapeutics for $300 million upfront. The buyout, which includes up to $2.15 billion in milestones, will give Bayer control of an eye disease implant that ...
UK banks still lack access to Mythos AI model, BoE's Bailey says Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions of people ...
While pesticides are making us sick, corporations like Bayer are seeking immunity from lawsuits over harms linked to their products. Their efforts are failing. While pesticides are making us sick, ...
The US Supreme Court gave Bayer AG a mixed reception on its bid to stop tens of thousands of lawsuits claiming its Roundup herbicide should have been labeled as a cancer risk. Hearing arguments in ...
This is the first in a three-part series on Bayer’s crusade for immunity from Roundup-related cancer claims, published in partnership with the Center for Media and Democracy. Read the second and third ...
A bill preventing states and local governments from issuing warnings about the risks of pesticides is on track to pass the House. In the eight years since it bought Monsanto—along with the liability ...
As Bayer AG tries to draw a line under costly Roundup herbicide litigation in the US this year, shareholders made clear at its annual general meeting that the stakes are higher than ever — including ...
Oral argument set for Monday in Bayer case seeking to block pesticide lawsuits New federal lobbying declaration records released last night reveal that Bayer ramped up federal lobbying in Q1 2026, ...
Bayer (BAYZF) (BAYRY) is confronting a pivotal moment in its long-running Roundup litigation as thousands of plaintiffs decide whether to accept a proposed $7.5 billion settlement or continue pursuing ...
New York, NY, March 31, 2026 (GLOBE NEWSWIRE) -- Following a challenge brought by OLLY PBC, BBB National Programs’ National Advertising Division recommended that Bayer HealthCare LLC discontinue or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results